95 completed, 13 unknown, 5 recruiting, 4 terminated. 125 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 125 | Completed 95, Unknown 13, Recruiting 5, Terminated 4, Not yet recruiting 3, Active not recruiting 2, Withdrawn 2, Enrolling by invitation 1 |
Follow Acneiform Eruptions: new trials by email Literature Review of Acneiform Eruptions trials Research Report on Acneiform Eruptions
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clascoterone Versus Clindamycin Added to Adapalene/Benzoyl Peroxide for Moderate Facial Acne Clascoterone 1% cream, Clindamycin 1% lotion, Adapalene 0.1%/benzoyl peroxide 2.5% gel - Acne Vulgaris | Phase 4 | Not yet recruiting | Allied Hospital Faisalabad | 118 | 2026-11-01 | 2026-10-19 |
| Clinical Evaluation of an Oil-Balancing Facial Sunscreen With Topical Tretinoin oil-balancing sunscreen - Acne | Phase 4 | Enrolling by invitation | Colgate Palmolive | 40 | 2026-10-28 | 2026-11-12 |
| Comparing Nadifloxacin Plus Tretinoin Versus Clindamycin Plus Tretinoin Creams for Mild-to-Moderate Acne nadifloxacin, Tretinoin Cream 0.025%, Clindamycin - Acne Vulgaris | Phase 4 | Recruiting | Nishtar Medical University | 158 | 2026-09-17 | 2026-11-04 |
| Low-Dose Versus Conventional-Dose Oral Isotretinoin for Acne Vulgaris Isotretinoin - Acne Vulgaris | Phase 4 | Not yet recruiting | Pakistan Institute of Medical Sciences | 164 | 2026-07-01 | 2026-06-10 |
| Comparing Sarecycline and Doxycycline Effects on the Skin and Gut Bacteria in Acne. Sarecycline, Doxycycline - Acne Vulgaris | Phase 4 | Recruiting | Integrative Skin Science and Research | 30 | 2026-04-20 | 2026-04-22 |
| Study to Assess Safety, Pharmacokinetics, and Treatment Effect of Cabtreo CABTREO is a fixed-combination product of clindamycin phosphate 1.2%/BPO 3.1%/adapalene 0.15%. - Acne Vulgaris | Phase 4 | Recruiting | Bausch Health Americas, Inc. | 100 | 2026-04-01 | 2026-07-29 |
| Safety, Tolerability, and Clinical Effectiveness of Adapalene/Clindamycin Phosphate Gel (Klenzit®-C) in Vietnamese Patients With Mild to Moderate Acne Vulgaris Klenzit®-C (Adapalene/Clindamycin Phosphate Gel) - Acne | Phase 4 | Recruiting | IR INNOVATE RESEARCH PRIVATE LIMITED | 225 | 2026-02-25 | 2026-11-05 |
| Metronidazole 2% Gel Versus Clindamycin 1% Gel for Moderate Acne Vulgaris Metronidazole Topical Gel 2%, Clindamycin Topical Gel 1% - Acne Vulgaris | Phase 4 | Not yet recruiting | Jinnah Postgraduate Medical Centre | 60 | 2026-02-01 | 2026-02-06 |
| Efficacy and Safety of Adapalene Gel and Hyaluronic Acid Versus Adapalene Gel Alone in Mild to Moderate Acne Vulgaris use of adapalene gel 0.1% and hyaluronic acid at bedtime, use of adapalene gel 0.1% once daily at bedtime - Acne Vulgaris | Phase 4 | Completed | Badr University | 93 | 2025-07-21 | 2026-10-30 |
| Randomized, Triple-Blind, Vehicle-Controlled Trial of Topical Dapsone Gel 7.5% in Patients With Acne Vulgaris Dapsone 7.5% gel, Vehicle gel - Acne Vulgaris | Phase 4 | Completed | Oya Helin Dundar | 100 | 2025-06-17 | 2026-05-22 |
| Efficacy of Oral Metformin vs Oral Doxycycline in Treating Acne Vulgaris oral metformin, Oral doxycycline - Acne Vulgaris on the Face, Acne Vulgaris | Phase 4 | Completed | Ghurki Trust and Teaching Hospital | 68 | 2025-02-15 | 2026-01-22 |
| A Study to Assess Sebaceous Gland Changes and Constituents of Sebum (Skin Oil) Induced by Clascoterone 1% Cream in Acne Patients Winlevi (Clascoterone) cream 1% - Acne Vulgaris | Phase 4 | Active not recruiting | Sun Pharmaceutical Industries Limited | 10 | 2024-07-01 | 2026-01-21 |
| A Study to Evaluate the Reduction in Sebum (Skin Oil) Induced by Clascoterone Cream 1% in Acne Patients Winlevi (clascoterone) 1% cream - Acne Vulgaris | Phase 4 | Completed | Sun Pharmaceutical Industries Limited | 40 | 2024-02-14 | 2026-06-15 |
| A Study to Evaluate the Impact of Clascoterone 1% Cream on Skin Barrier Properties in Acne Prone Patients Winlevi (clascoterone) 1% cream - Acne Vulgaris | Phase 4 | Completed | Sun Pharmaceutical Industries Limited | 50 | 2023-11-27 | 2025-03-04 |
| A Study Assessing the Efficacy and Safety of Combined Use of Clascoterone 1% Cream and Duac Gel (Benzoyl Peroxide/Clindamycin) for the Treatment of Acne Winlevi (clascoterone) 1% & Duac gel - Acne Vulgaris | Phase 4 | Completed | Sun Pharmaceutical Industries Limited | 10 | 2023-11-15 | 2025-07-17 |
| A Study Assessing the Efficacy of Combined Use of Clascoterone 1% Cream and Adapalene 0.3% for the Treatment of Acne Winlevi (clascoterone) 1% & Adapalene 0.3% gel - Acne Vulgaris | Phase 4 | Completed | Sun Pharmaceutical Industries Limited | 20 | 2023-11-15 | 2025-10-09 |
| A Study Evaluating the Efficacy and Safety of Clascoterone Cream 1% in Skin of Color Patients With Acne Winlevi (clascoterone) 1% cream - Acne Vulgaris | Phase 4 | Completed | Sun Pharmaceutical Industries Limited | 10 | 2023-09-01 | 2026-01-16 |
| The Efficacy and Safety of Topical Vitamin D and Supplementation In Acne Vulgaris The Study of VDR, IL-1β, IL-6, IL-10 and IL-17 Expression combination oral and topical vitamin D, oral placebo and topical cholecalciferol, oral placebo and basic ingredient placebo topical vitamin D - Acne Vulgaris, Vitamin D | Phase 4 | Unknown | Universitas Indonesia | 105 | 2023-02-16 | 2023-03-07 |
| Comparison Between Isotretinoin, Silymarin and Both in the Treatment of Acne Vulgaris Isotretinoin ,silymarin - Acne Vulgaris | Phase 4 | Unknown | Tanta University | 75 | 2023-01-01 | 2022-12-28 |
| Impact of Isotretinoin in Different Doses on Quality of Life Isotretinoin - Acne Vulgaris | Phase 4 | Unknown | Assiut University | 100 | 2022-12-01 | 2022-04-07 |
Showing 20 of 125. Sign in to see all of them.
Acne Vulgaris (122) · Hyperpigmentation (4) · Acne Keloid (2) · Cicatrix (2) · Erythema (2) · Alopecia Areata (1) · Amenorrhea (1) · Cicatrix, Hypertrophic (1) · Dermoid Cyst (1) · Dyslipidemias (1) · Glucosephosphate Dehydrogenase Deficiency (1) · Granuloma Annulare (1) · Hirsutism (1) · Inflammation (1)
Skin and Connective Tissue Diseases (125) · Skin Diseases (124) · Sebaceous Gland Diseases (122) · Pathological Conditions, Signs and Symptoms (7) · Pathologic Processes (6) · Hair Diseases (4) · Pigmentation Disorders (4) · Collagen Diseases (3) · Connective Tissue Diseases (3) · Fibrosis (3) · Neoplasms (3) · Signs and Symptoms (3) · Cysts (2) · Folliculitis (2)
Adapalene (26) · Benzoyl Peroxide (22) · Gels (21) · Clindamycin (18) · Dapsone (12) · Adapalene, Benzoyl Peroxide Drug Combination (11) · Doxycycline (11) · Tretinoin (11) · Isotretinoin (9) · Clascoterone (7) · Salicylic Acid (7) · clindamycin phosphate (6) · clindamycin phosphate benzoyl peroxide combination (6) · Minocycline (5) · tazarotene (5)
Galderma R&D (19) · Stiefel, a GSK Company (14) · Sun Pharmaceutical Industries Limited (7) · Allergan (6) · Bausch Health Americas, Inc. (6) · Assiut University (5) · Derm Research, PLLC (5) · Wake Forest University (4) · GlaxoSmithKline (2) · Zeichner, Joshua, M.D. (2) · All India Institute of Medical Sciences, Bhubaneswar (1) · Allied Hospital Faisalabad (1) · Almirall, S.A. (1) · Alshimaa Abbas Mohamed Ebrahim (1) · Aswan University (1)
United States (72) · Canada (7) · Germany (5) · Egypt (4) · Pakistan (4) · France (3) · United Kingdom (3) · Brazil (2) · Netherlands (2) · Poland (2) · Spain (2) · Argentina (1) · China (1) · India (1) · Indonesia (1)
Leon H. Kircik, M.D. (3) · Ronald W Gottschalk, MD (3) · Ana Rossi, MD (2) · David Lineberry (2) · Michael Graeber, MD (2) · A Chu, MB BS, FRCP (1) · A Langner, MD, DSc (1) · Adelaide Hebert, MD (1) · Alan Fleischer, MD (1) · Alessandra T Nogueira, MD (1) · Ana B Rossi, MD (1) · Andrea Zaenglein, MD (1)
PMID 20684151, PMID 10951254, PMID 11488820, PMID 12095065, PMID 12243706, PMID 12553848, PMID 12839559, PMID 16575387, PMID 18249468, PMID 18472984, PMID 19075138, PMID 19376456, PMID 19439902, PMID 19911678, PMID 20213916, PMID 20214175, PMID 20677537, PMID 20981308, PMID 22341881, PMID 22837561, PMID 23513559, PMID 23652892, PMID 25003376, PMID 25074072, PMID 25973678, PMID 26897386, PMID 27177989, PMID 27514932, PMID 28573779, PMID 28678647, PMID 28913735, PMID 29027127, PMID 29036256, PMID 29369333, PMID 29537444, PMID 31080813, PMID 31163231, PMID 31720190, PMID 31844016, PMID 32038751, PMID 32424832, PMID 33760691, PMID 34104156, PMID 34478863, PMID 36568833, PMID 36880295, PMID 37190684, PMID 37777343, PMID 37838987, PMID 38300170
2016 (1), U01AR079752 (1)